Non-peptide arginine-vasopressin antagonists: the vaptans
G Decaux, A Soupart, G Vassart - The Lancet, 2008 - thelancet.com
Arginine-vasopressin is a hormone that plays an important part in circulatory and water
homoeostasis. The three arginine-vasopressin-receptor subtypes—V1a, V1b, and V2—all …
homoeostasis. The three arginine-vasopressin-receptor subtypes—V1a, V1b, and V2—all …
Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications
C Urso, S Brucculeri, G Caimi - Heart failure reviews, 2015 - Springer
Electrolyte and acid–base abnormalities are a frequent and potentially dangerous
complication in subjects with congestive heart failure. This may be due either to the …
complication in subjects with congestive heart failure. This may be due either to the …
Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia
RW Schrier, P Gross, M Gheorghiade… - … England Journal of …, 2006 - Mass Medical Soc
Background Hyponatremia (serum sodium concentration,< 135 mmol per liter) is a predictor
of death among patients with chronic heart failure and cirrhosis. At present, therapy for acute …
of death among patients with chronic heart failure and cirrhosis. At present, therapy for acute …
Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure
JM Testani, JS Hanberg, JP Arroyo… - European journal of …, 2016 - Wiley Online Library
Aims Hyponatraemia is strongly associated with adverse outcomes in heart failure.
However, accumulating evidence suggests that chloride may play an important role in renal …
However, accumulating evidence suggests that chloride may play an important role in renal …
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension
PR Forfia, SC Mathai, MR Fisher… - American journal of …, 2008 - atsjournals.org
Rationale: Hyponatremia is associated with decompensated heart failure and poor
prognosis in patients with left ventricular systolic dysfunction. Objectives: We sought to …
prognosis in patients with left ventricular systolic dysfunction. Objectives: We sought to …
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and …
JE Udelson, FA McGrew, E Flores, H Ibrahim… - Journal of the American …, 2007 - jacc.org
Objectives: This study sought to examine the effects of vasopressin V2receptor antagonism
with tolvaptan on the changes in left ventricular (LV) volumes over time. Background …
with tolvaptan on the changes in left ventricular (LV) volumes over time. Background …
Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry)
N Sato, M Gheorghiade, K Kajimoto… - The American journal of …, 2013 - Elsevier
Hyponatremia is known to be a poor prognostic factor in patients hospitalized with heart
failure (HF), however not well studied in Japan. The aims of this study were to characterize …
failure (HF), however not well studied in Japan. The aims of this study were to characterize …
[HTML][HTML] Hyponatremia in patients with heart failure
TD Filippatos, MS Elisaf - World journal of cardiology, 2013 - ncbi.nlm.nih.gov
The present review analyses the mechanisms relating heart failure and hyponatremia,
describes the association of hyponatremia with the progress of disease and …
describes the association of hyponatremia with the progress of disease and …
Electrolyte and acid-base disorders in cancer patients and its impact on clinical outcomes: evidence from a real-world study in China
Y Li, X Chen, Z Shen, Y Wang, J Hu, J Xu, B Shen… - Renal …, 2020 - Taylor & Francis
Background This study aims to delineate the incidence of electrolyte and acid-base
disorders (EAD) in cancer patients, to figure out the risk factors of EAD, then to assess the …
disorders (EAD) in cancer patients, to figure out the risk factors of EAD, then to assess the …
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions
Hyponatremia in heart failure (HF) is an established predictor of adverse outcomes in
hospitalized patients with reduced ejection fraction (EF). However, there is a paucity of data …
hospitalized patients with reduced ejection fraction (EF). However, there is a paucity of data …